Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5971987 | 0.91 | MEN1 (0.59) | MAPTMEN1KMT2AGPR84HDAC3 | |
| SCHEMBL3566797 | 0.91 | HDAC3 (0.57) | MAPTMEN1KMT2AGPR84HDAC3 | |
| SCHEMBL5971960 | 0.82 | HTR6 (0.50) | MAPTHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL30091335 | 0.82 | LMNA (0.49) | MAPTMEN1KMT2AGPR84HDAC3 | |
| SCHEMBL30091143 | 0.80 | MET (0.58) | MAPTMEN1KMT2AHDAC3HDAC4 | |
| SCHEMBL28920451 | 0.80 | MET (0.58) | MAPTMEN1KMT2AHDAC3HDAC4 | |
| SCHEMBL18591261 | 0.80 | GPR84 (0.50) | MAPTMEN1KMT2AGPR84NR4A2 | |
| SCHEMBL18555016 | 0.80 | GPR84 (0.50) | MAPTMEN1KMT2AGPR84CA12 | |
| SCHEMBL22158064 | 0.79 | FEN1 (0.44) | MAPTGPR84HDAC3HDAC4HDAC1 | |
| SCHEMBL3574514 | 0.78 | HDAC3 (0.48) | MAPTMEN1KMT2AHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2025-01-21 | — | — | US | claimed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | claimed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | claimed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | claimed |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2025-01-21 | — | — | US | disclosed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | CFD RESEARCH CORPORATION (US) | 2021-11-23 | — | — | US | disclosed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RESEARCH CORPORATION | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12202798-B2 | Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes | ZYX, IDO1, CRY1 | MAPT 272/4885MEN1 1296/4885KMT2A 2903/4885 |
| US-11180452-B2 | Methods and compositions for selectively inhibiting pathogenic microbes | FPR1, FPR3, ARG1 | MAPT 1240/4885MEN1 1299/4885KMT2A 3060/4885 |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | MAPT 48/4885MEN1 2402/4885KMT2A 4633/4885 |
| US-20200399217-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | FPR1, FPR3, ARG1 | MAPT 1240/4885MEN1 1299/4885KMT2A 3060/4885 |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | MAPT 48/4885MEN1 2402/4885KMT2A 4633/4885 |
| US-20200399218-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | ZYX, IDO1, CRY1 | MAPT 272/4885MEN1 1296/4885KMT2A 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.